Overview

Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section

Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
Purpose to evaluates the effects of oxytocin infusion with or without intravenous tranexamic acid (TA) in comparison with Carbetocin for prevention of postpartum hemorrhage at a cesarean section with one or more risk factor for postpartum hemorrhage.
Phase:
N/A
Details
Lead Sponsor:
Aswan University Hospital
Treatments:
Carbetocin
Oxytocin
Pharmaceutical Solutions
Tranexamic Acid